Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL
Plain-language summary
This study is developing and validating improved flow cytometry methods to better detect circulating tumor cells in patients with cutaneous T-cell lymphoma (CTCL), including mycosis fungoides or Sézary syndrome. No experimental treatment is given as part of this study. This trial does not currently have sites in the United States.
Who can join (key eligibility)
- Age 18 Years or older
- See full trial listing for complete eligibility
Final eligibility is determined by the trial team. This list is a starting point only.
What's being tested
Detection and quantitation of (blood) tumor cells in patients with mycosis fungoides (MF) / Sézary syndrome (SS). (DIAGNOSTIC_TEST): Specific, sensitive, and reproducible (blood) detection and quantitation of tumor cells in patients with mycosis fungoides (MF) / Sézary syndrome (SS)
Detection and quantitation of (blood) tumor cells in patients with mycosis fungoides (MF) / Sézary syndrome (SS).
- Treatment length
- Ask the trial team for details
- Visit frequency
- Ask the trial team for details